Merus N.V. MRUS
$ 43.83
2.1%
Quarterly report 2024-Q3
added 10-31-2024
Country |
Niderland |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Ton Logtenberg |
Employees in the company |
87 |
Shares |
51.6 M |
Market Cap[1] |
$ 2.26 B |
EBITDA (LTM) |
$ -160 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.